Cañales, Renelia .
HRN: 01-62-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
CEFTAZIDIME 1GM (VIAL)
01/03/2023
01/09/2023
IV
1g
Q8
CAP-MR, T/C PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes